Double-blind, placebo-controlled trial of asenapine in prevention of relapse after long-term treatment of schizophrenia

被引：0
|
作者：
Kane, J. M. [1 ]
Mackle, M. [1 ]
Snow-Adami, L. [1 ]
Zhao, J. [1 ]
Szegedi, A. [1 ]
Panagides, J. [1 ]
机构：
[1] Zucker Hillside Hosp, Glen Oaks, NY USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [1] Double-blind, placebo-controlled trial of asenapine in prevention of relapse after long-term treatment of schizophrenia
    Mackle, M.
    Snow-Adami, L.
    Zhao, J.
    Szegedi, A.
    Panagides, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S543 - S543
  • [2] A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment
    Kane, John M.
    Mackle, Mary
    Snow-Adami, Linda
    Zhao, Jun
    Szegedi, Armin
    Panagides, John
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (03) : 349 - 355
  • [3] Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: a double-blind, placebo-controlled trial
    Durgam, S.
    Earley, W.
    Li, R.
    Li, D.
    Lu, K.
    Laszlovszky, I.
    Fleischhacker, W. W.
    Lieberman, J. A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S512 - S513
  • [4] Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial
    Durgam, Suresh
    Earley, Willie
    Li, Rui
    Li, Dayong
    Lu, Kaifeng
    Laszlovszky, Istvan
    Fleischhacker, W. Wolfgang
    Nasrallah, Henry A.
    SCHIZOPHRENIA RESEARCH, 2016, 176 (2-3) : 264 - 271
  • [5] Long-Term Cariprazine Treatment for the Prevention of Relapse in Patients with Schizophrenia: Additional Analysis from a Randomized, Double-Blind, Placebo-Controlled Trial
    Durgam, Suresh
    Earley, Willie
    Li, Rui
    Li, Dayong
    Lu, Kaifeng
    Laszlovszky, Istvan
    Edwards, John
    Nasrallah, Henry
    Fleischhacker, W.
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S380 - S381
  • [6] LONG-TERM REMISSION WITH CARIPRAZINE TREATMENT IN PATIENTS WITH SCHIZOPHRENIA: A POST HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, RELAPSE PREVENTION TRIAL
    Potkin, Steven
    Correll, Christoph
    Chang, Cheng-Tao
    Szatmari, Balÿzs
    Laszlovszky, Istvan
    Earley, Willie
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S118 - S118
  • [7] Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Trial
    Lauriello, John
    Perkins, Diana O.
    JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (02)
  • [8] Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial (vol 176, pg 264, 2016)
    Durgam, Suresh
    Earley, Willie
    Li, Rui
    Li, Dayong
    Lu, Kaifeng
    Laszlovszky, Istvan
    Fleischhacker, W. Wolfgang
    Nasrallah, Henry A.
    SCHIZOPHRENIA RESEARCH, 2018, 192 : 493 - 493
  • [9] A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse
    Beasley, CM
    Sutton, VK
    Hamilton, SH
    Walker, DJ
    Dossenbach, M
    Taylor, CC
    Alaka, KJ
    Bykowski, D
    Tollefson, GD
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (06) : 582 - 594
  • [10] Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial
    Bonderup, O. K.
    Hansen, J. B.
    Teglbjaerg, P. S.
    Christensen, L. A.
    Fallingborg, J. F.
    GUT, 2009, 58 (01) : 68 - 72
12345